Portfolio Holdings Detail for ISIN IE00B0M63730

Stock Name / Fund	iShares MSCI AC Far East ex-Japan UCITS ETF USD (Dist) USD
Issuer	Blackrock
Entity holding fund	iShares Public Limited Company
Entity Type
Entity LEI	549300YDM1GFZR5B4U80
ETF Ticker	IDFF(USD) LSE
ETF Ticker	IQQF(EUR) F
ETF Ticker	IDFF.LS(USD) CXE
ETF Ticker	IFFF.LS(GBX) CXE
ETF Ticker	IFFF.MI(EUR) CXE
ETF Ticker	IFFFz(USD) CXE
ETF Ticker	IQQF.DE(EUR) CXE
ETF Ticker	IFFF(EUR) ETF Plus
ETF Ticker	IDFF.L(GBP) LSE

Holdings detail for LEGN

Show aggregate LEGN holdings

News associated with LEGN

Brokerages Set Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Price Target at $74.22

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven ratings firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average 12 month price […] - 2025-09-19 02:43:01

Legend Biotech Becomes Oversold (LEGN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me - 2025-09-10 14:53:11

JPMorgan Chase & Co. Increases Legend Biotech (NASDAQ:LEGN) Price Target to $78.00

Legend Biotech (NASDAQ:LEGN – Get Free Report) had its price target raised by research analysts at JPMorgan Chase & Co. from $77.00 to $78.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of […] - 2025-08-27 02:30:45

Legend Biotech Breaks Below 200-Day Moving Average - Notable for LEGN

In trading on Monday, shares of Legend Biotech Corp (Symbol: LEGN) crossed below their 200 day moving average of $36.28, changing hands as low as $35.23 per share. Legend Biotech Corp shares are currently trading off about 2.5% on the day. The chart below shows the one year pe - 2025-08-11 12:46:01

Legend Biotech (NASDAQ:LEGN) Rating Increased to Strong-Buy at Cantor Fitzgerald

Legend Biotech (NASDAQ:LEGN – Get Free Report) was upgraded by analysts at Cantor Fitzgerald to a “strong-buy” rating in a note issued to investors on Monday,Zacks.com reports. Other equities research analysts also recently issued research reports about the company. Johnson Rice reissued a “buy” rating on shares of Legend Biotech in a research report on […] - 2025-08-06 03:12:50

GAMMA Investing LLC Boosts Position in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN)

GAMMA Investing LLC increased its holdings in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Free Report) by 145.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,291 shares of the company’s stock after purchasing an additional 765 […] - 2025-07-11 04:12:51

Legend Biotech (NASDAQ:LEGN) Receives Buy Rating from HC Wainwright

Legend Biotech (NASDAQ:LEGN – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They currently have a $75.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 90.07% from the company’s previous close. A number of other […] - 2025-07-10 04:01:26

Rhumbline Advisers Purchases 391 Shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN)

Rhumbline Advisers lifted its position in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Free Report) by 1.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,029 shares of the company’s stock after acquiring an additional 391 shares during the quarter. Rhumbline Advisers’ holdings […] - 2025-06-20 04:25:11

Thursday's ETF with Unusual Volume: FTQI

The First Trust Nasdaq BuyWrite Income ETF is seeing unusually high volume in afternoon trading Thursday, with over 909,000 shares traded versus three month average volume of about 226,000. Shares of FTQI were down about 0.2% on the day. Components of that ETF with the highest - 2025-06-12 15:09:39

Tuesday's ETF with Unusual Volume: EEMA

The iShares MSCI Emerging Markets Asia ETF is seeing unusually high volume in afternoon trading Tuesday, with over 2.5 million shares traded versus three month average volume of about 92,000. Shares of EEMA were up about 0.3% on the day. Components of that ETF with the highest - 2025-06-10 14:57:32

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 36,181 Shares of Legend Biotech Co. (NASDAQ:LEGN)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 36.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 136,438 shares of the company’s stock after […] - 2025-06-04 05:02:51

Nuveen Asset Management LLC Acquires 5,700 Shares of Legend Biotech Co. (NASDAQ:LEGN)

Nuveen Asset Management LLC grew its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 5.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 110,586 shares of the company’s stock after purchasing an additional 5,700 shares during the period. Nuveen Asset Management LLC’s […] - 2025-06-02 05:04:55

Legend Biotech Co. (NASDAQ:LEGN) Shares Acquired by Squarepoint Ops LLC

Squarepoint Ops LLC grew its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 44.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 127,900 shares of the company’s stock after acquiring an additional 39,197 shares during the quarter. Squarepoint Ops […] - 2025-05-27 05:13:00

Millennium Management LLC Has $8.31 Million Holdings in Legend Biotech Co. (NASDAQ:LEGN)

Millennium Management LLC lessened its stake in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 55.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 255,468 shares of the company’s stock after selling 314,908 shares during the quarter. Millennium Management LLC’s […] - 2025-05-26 04:42:54

Deutsche Bank AG Acquires 14,198 Shares of Legend Biotech Co. (NASDAQ:LEGN)

Deutsche Bank AG lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 11.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 135,067 shares of the company’s stock after acquiring an additional 14,198 shares during the period. Deutsche Bank […] - 2025-05-20 05:12:55

Legend Biotech (NASDAQ:LEGN) Hits New 12-Month Low After Analyst Downgrade

Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after Truist Financial lowered their price target on the stock from $88.00 to $71.00. Truist Financial currently has a buy rating on the stock. Legend Biotech traded as low as $27.54 and last traded at […] - 2025-05-16 03:02:47

Legend Biotech Co. (NASDAQ:LEGN) Stake Boosted by Stifel Financial Corp

Stifel Financial Corp increased its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 70.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,365 shares of the company’s stock after acquiring an additional 12,955 shares […] - 2025-05-09 05:58:54

Zurcher Kantonalbank Zurich Cantonalbank Trims Position in Legend Biotech Co. (NASDAQ:LEGN)

Zurcher Kantonalbank Zurich Cantonalbank decreased its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 18.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 40,913 shares of the company’s stock after selling 9,355 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Legend […] - 2025-03-19 05:40:51

Morgan Stanley Issues Pessimistic Forecast for Legend Biotech (NASDAQ:LEGN) Stock Price

Legend Biotech (NASDAQ:LEGN – Get Free Report) had its target price dropped by analysts at Morgan Stanley from $82.00 to $80.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s target price points to a potential upside of 111.19% from the company’s current […] - 2025-03-19 04:28:56

Daiwa Securities Group Inc. Raises Stock Position in Legend Biotech Co. (NASDAQ:LEGN)

Daiwa Securities Group Inc. lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 165.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 8,516 shares of the company’s stock after acquiring an additional 5,309 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Legend Biotech were worth $278,000 as […] - 2025-03-17 06:06:55

Company News for Mar 12, 2025

Companies in The News Are: FRG, ORCL, LEGN, PAY - 2025-03-12 11:20:00

Legend Biotech Co. (NASDAQ:LEGN) Receives $79.50 Average PT from Brokerages

Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) have been given a consensus rating of “Buy” by the twelve research firms that are covering the stock, MarketBeat Ratings reports. Twelve analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the stock […] - 2025-03-03 04:50:55

Legend Biotech Co. (NASDAQ:LEGN) Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lowered its stake in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 2.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 173,766 shares of the company’s stock after selling 3,461 shares during the quarter. Sumitomo Mitsui Trust […] - 2025-02-14 07:35:09

Contrasting Legend Biotech (NASDAQ:LEGN) and COMPASS Pathways (NASDAQ:CMPS)

COMPASS Pathways (NASDAQ:CMPS – Get Free Report) and Legend Biotech (NASDAQ:LEGN – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Earnings & Valuation This table compares COMPASS Pathways […] - 2025-02-06 04:06:58

How The Parts Add Up: KOMP Headed For $62

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-02-04 10:28:33

iShares MSCI AC Far East ex-Japan UCITS ETF USD (Dist) USD LEGN holdings

Date	Number of LEGN Shares Held	Base Market Value of LEGN Shares	Local Market Value of LEGN Shares	Change in LEGN Shares Held	Change in LEGN Base Value	Current Price per LEGN Share Held	Previous Price per LEGN Share Held
2025-11-27 (Thursday)	10,399	USD 285,973	USD 285,973	0	USD 0	USD 27.5	USD 27.5
2025-11-26 (Wednesday)	10,399	USD 285,973	USD 285,973	0	USD -7,175	USD 27.5	USD 28.19
2025-11-25 (Tuesday)	10,399	USD 293,148	USD 293,148	0	USD 10,815	USD 28.19	USD 27.15
2025-11-24 (Monday)	10,399	USD 282,333	USD 282,333	0	USD -10,607	USD 27.15	USD 28.17
2025-11-21 (Friday)	10,399	USD 292,940	USD 292,940	0	USD 6,656	USD 28.17	USD 27.53
2025-11-20 (Thursday)	10,399	USD 286,284	USD 286,284	0	USD -4,888	USD 27.53	USD 28
2025-11-19 (Wednesday)	10,399	USD 291,172	USD 291,172	0	USD -14,767	USD 28	USD 29.42
2025-11-18 (Tuesday)	10,399	USD 305,939	USD 305,939	0	USD -3,119	USD 29.42	USD 29.72
2025-11-17 (Monday)	10,399	USD 309,058	USD 309,058	0	USD -5,928	USD 29.72	USD 30.29
2025-11-14 (Friday)	10,399	USD 314,986	USD 314,986	0	USD -7,487	USD 30.29	USD 31.01
2025-11-13 (Thursday)	10,399	USD 322,473	USD 322,473	0	USD -1,716	USD 31.01	USD 31.175
2025-11-12 (Wednesday)	10,399	USD 324,189	USD 324,189	0	USD -8,891	USD 31.175	USD 32.03
2025-11-11 (Tuesday)	10,399	USD 333,080	USD 333,080	-134	USD 343	USD 32.03	USD 31.59
2025-11-10 (Monday)	10,533	USD 332,737	USD 332,737	0	USD -2,212	USD 31.59	USD 31.8

Share Trades of LEGN by Blackrock for IE00B0M63730

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-11	SELL	-134	32.570	31.310	31.436	USD -4,212	35.59 Profit of 557 on sale
2025-08-15	BUY	335	37.500	38.352	38.267	USD 12,819	36.17
2025-08-13	BUY	134	36.930	37.990	37.884	USD 5,076	36.16
2025-08-06	BUY	67	37.660	38.465	38.385	USD 2,572	36.13
2025-08-04	BUY	603	38.450	39.100	39.035	USD 23,538	36.10
2025-07-15	SELL	-469	39.590	40.430	40.346	USD -18,922	36.08 Loss of -2,000 on sale
2025-07-02	SELL	-67	35.910	36.770	36.684	USD -2,458	35.99 Loss of -46 on sale
2025-06-26	BUY	670	33.480	33.620	33.606	USD 22,516	36.02
2025-06-05	SELL	-402	31.480	32.180	32.110	USD -12,908	36.13 Profit of 1,615 on sale
2025-05-30	SELL	-2,210	28.950	29.070	29.058	USD -64,218	36.35 Profit of 16,112 on sale
2025-05-21	BUY	164	28.330	31.120	30.841	USD 5,058	36.80
2025-04-23	BUY	1,173	34.300	35.319	35.217	USD 41,310	37.78
2025-04-22	BUY	148	34.480	34.510	34.507	USD 5,107	37.81
2025-02-21	BUY	74	39.700	40.000	39.970	USD 2,958	40.01
2024-12-30	SELL	-148	32.770	32.913	32.899	USD -4,869	42.39 Profit of 1,405 on sale
2024-12-03	BUY	222	43.680	43.850	43.833	USD 9,731	42.59
2024-11-18	SELL	-148	37.420	39.690	39.463	USD -5,841	43.53 Profit of 601 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LEGN

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.